Recommendations for newborn screening for galactokinase deficiency: A systematic review and evaluation of Dutch newborn screening data.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Stroek, KevinBouva, Marelle J
Schielen, Peter C J I
Vaz, Frédéric M
Heijboer, Annemieke C
de Jonge, Robert
Boelen, Anita
Bosch, Annet M
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Recommendations for newborn screening for galactokinase deficiency: A systematic review and evaluation of Dutch newborn screening data.Published in
Mol Genet Metab 2018; 124(1):50-6Publiekssamenvatting
Galactokinase (GALK) deficiency causes cataract leading to severe developmental consequences unless treated early. Because of the easy prevention and rapid reversibility of cataract with treatment, the Dutch Health Council advised to include GALK deficiency in the Dutch newborn screening program. The aim of this study is to establish the optimal screening method and cut-off value (COV) for GALK deficiency screening by performing a systematic review of the literature of screening strategies and total galactose (TGAL) values and by evaluating TGAL values in the first week of life in a cohort of screened newborns in the Netherlands.PMID
29580649ae974a485f413a2113503eed53cd6c53
10.1016/j.ymgme.2018.03.008
Scopus Count
Collections
Related articles
- Nine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes.
- Authors: Welling L, Boelen A, Derks TG, Schielen PC, de Vries M, Williams M, Wijburg FA, Bosch AM
- Issue date: 2017 Mar
- Establishing New Cut-Off Limits for Galactose 1-Phosphate-Uridyltransferase Deficiency for the Dutch Newborn Screening Programme.
- Authors: Kemper EA, Boelen A, Bosch AM, van Veen-Sijne M, van Rijswijk CN, Bouva MJ, Fingerhut R, Schielen PC
- Issue date: 2017
- Early cataract formation due to galactokinase deficiency: impact of newborn screening.
- Authors: Janzen N, Illsinger S, Meyer U, Shin YS, Sander J, Lücke T, Das AM
- Issue date: 2011 Oct
- Ultra fast and sensitive liquid chromatography tandem mass spectrometry based assay for galactose-1-phosphate uridylyltransferase and galactokinase deficiencies.
- Authors: Li Y, Ptolemy AS, Harmonay L, Kellogg M, Berry GT
- Issue date: 2011 Jan
- Newborn screening for galactosemia: a 30-year single center experience.
- Authors: Porta F, Pagliardini S, Pagliardini V, Ponzone A, Spada M
- Issue date: 2015 May